Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Esophageal Neoplasms 3Brain Neoplasms 3Sarcoma 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Osteosarcoma 2Craniopharyngioma 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Vascular Neoplasms 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Recurrent Head and Neck Carcinoma 1Oligodendroglioma 1Neurofibrosarcoma 1Neuroblastoma 1Nerve Sheath Neoplasms 1Neoplasms, Adipose Tissue 1Neoplasms 1Myoepithelioma 1Mesothelioma, Malignant 1Meningioma 1Liposarcoma, Myxoid 1Liposarcoma 1Hodgkin Disease 1Histiocytoma, Angiomatoid Fibrous 1Hemangiosarcoma 1

Interventions

Magnetic Resonance Spectroscopy 22Temozolomide 17Specimen Handling 13X-Rays 9Biopsy 9Radiotherapy 8Radiation 8trametinib 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 6Bevacizumab 6larotrectinib 4erdafitinib 4dabrafenib 4ulixertinib 3palbociclib 3abemaciclib 3Surgical Procedures, Operative 3Nivolumab 3Cyclophosphamide 3vorasidenib 2tipifarnib 2tazemetostat 2selpercatinib 2olaparib 2mirdametinib 2lutetium Lu 177 dotatate 2ivosidenib 2fluorodopa F 18 2fludarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Proton Therapy × 90 days × Clear all
NCT03180502 2026-05-26

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

NRG Oncology

Phase 2 Active not recruiting
120 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡